FIELD: medicine, leprology.
SUBSTANCE: the present innovation deals with predicting exacerbation of leprous neuropathies in patients at leprosy and neuropathies of nonleprous etiology. In patients at leprosy one should detect antibodies to antigen of peripheral nerves in blood serum. According to the availability of antibodies to ceramide in blood serum and at their increased level from 0.26 U optic density and higher one should predict the exacerbation of leprous neuropathies in patients at leprosy.
EFFECT: higher accuracy of prediction.
4 dwg, 4 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| METHOD OF LEPROSY DIAGNOSIS | 1996 |
|
RU2124730C1 |
| METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
| METHOD OF IDENTIFICATION OF MYCOBACTERIUM LEPRAE IN PATIENTS WITH DISEASE REGRESSION | 1997 |
|
RU2137137C1 |
| METHOD FOR PREDICTING LEPROUS NODULAR ERYTHEMA PROGRESS | 2000 |
|
RU2171991C1 |
| METHOD OF MONITORING EFFECTIVENESS OF TREATING CHRONIC MYCOBACTERIOSIS | 2007 |
|
RU2354971C1 |
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
| METHOD OF DETECTION OF SPECIFIC LIVER DISEASE IN LEPROSY PATIENTS | 2009 |
|
RU2403869C1 |
| METHOD FOR TYPING LEPROMATOUS LEPROSY | 2009 |
|
RU2415431C1 |
